Trump Says 'No Cash' to mRNA, Investors Say 'Bye Bye'
The Trump administration decided to pull the plug on nearly $500 million meant for mRNA vaccine research, leaving biotech investors nervously clutching their wallets. According to reports, the cut "has made investors more hesitant to back biotechs in this space," which is just a polite way of saying they got cold feet. It's like sitting at a promising restaurant table, then watching the host cancel your reservation right before the appetizer. Science funding or lottery? Either way, no surprise funds went "poof."
Share the Story
Cutting $500M for vaccine research is like closing a lemonade stand right before summer. Genius moves from the admin that make everyone in biotech wanna sell popcorn instead.
Investors gotta be wondering if funding mRNA research feels like betting on a unicorn or a facade. Spoiler: unicorns need money too.
Trump halts mRNA cash flow, biotech investors duck faster than you running from your 8 AM Zoom. Science just got ghosted.
Source: Statnews | Published: 8/14/2025 | Author: Jonathan Wosen and Allison DeAngelis
More Articles in Politics
Digital Nomad Trapped in Lisbon FOMO, Ends Up BFF Ghosted
Grandfather Gifts $1,500 with Guest Star Role for Financial Advisor
TCL and Hisense Finally Throw Shade at Sony, LG, Samsungās Premium TV Party
Republicans Suddenly Love Invasions Now That Maduro's Captured Like A Limited-Edition Funko Pop
UK Warns Future PM Might Just Be Kremlin's Favorite Karaoke Partner
Trump Flexes Donroe Doctrine, Threatens Latvia Then Asks About Greenland Price
Congress Defends Masked ICE Agent Amid SUV-Adjacent Gunfire Drama
US Seriously Weighs Invading Greenland Because 'Itās Just Too Cold to Ignore'
